APTAFIN S P A enters REGENERX BIOPHARMACEUTICALS INC with 1.50M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 7/19/2021ACC: 0001213900-21-037494
1.50M
Baseline shares
100% direct
1.50M
Direct ownership
1 position
2.25M
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned1.50M
Total
1.50M direct1.50M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.50M | Direct |
| Total | 1.50M | 1.50M direct |
Derivative Holdings2
Common Stock Warrant (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
1.13M
Shares owned
N/A
Exercise price
0.24
Expiration
—
Exercise window
—
Common Stock Warrant (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
1.13M
Shares owned
N/A
Exercise price
0.28
Expiration
—
Exercise window
—
Total
Underlying
2.25M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Common Stock Warrant (right to buy) Direct | Common Stock | 0.24 | — | — | 1.13M | N/A |
| Common Stock Warrant (right to buy) Direct | Common Stock | 0.28 | — | — | 1.13M | N/A |
| Total | 2.25M | 0.00 | ||||